Acute cholestatic hepatitis induced by cerivastatin [3]

Medicina Clinica

Volumn 118, Issue 18, 2002, Pages 717-

  Torres, Miquel ^a   Sobrino, Javier ^a   Asensio, Carmen ^a   López, Dolors ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CERIVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIDINE DERIVATIVE;

ACUTE DISEASE; AGED; CASE REPORT; CHEMICALLY INDUCED DISORDER; CHOLESTASIS; HUMAN; LETTER; MALE; TOXIC HEPATITIS; CHOLESTATIC HEPATITIS; DRUG INDUCED DISEASE; ECHOGRAPHY; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; LABORATORY TEST; LIVER BIOPSY; PHYSICAL EXAMINATION; SEROLOGY;

ACUTE DISEASE; AGED; CHOLESTASIS; HEPATITIS, TOXIC; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PYRIDINES;

EID: 0037129746     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7753(02)72507-4     Document Type: Letter

References (10)

1. Efficacy and safety of 300 μg and 400 μg cerivastatin once daily in patients with primary hipercholesterolaemia: A multicentre, randomized, double-blind, placebo-controlled study
2. Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1030 hypercholesterolemic patients
3. Alteraciones del metabolismo de las lipoproteínas
4. Hepatitis inducida por lovastatina
5. Hepatitis asociada al tratamiento con lovastatina. Presentación de 2 casos
6. Simvastatin-induced hepatitis
7. Acute cholestatic hepatitis associated with pravastatin
8. Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erytematous
9. Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin
10. Comunicación sobre riesgos de medicamentos. Cerivastatina y casos de rabdomiólisis